Features of portal hypertension are associated with major adverse events in Fontan patients: The VAST study
Robert W. Elder(Yale University), Wendy Book(Emory University), Camden L. Hebson(University of Alabama at Birmingham), Brian Kogon(Children's Healthcare of Atlanta), Maan Jokhadar(Emory University), William T. Mahle(Children's Center), René Romero(Emory University), Anurag Sahu(Emory University), Michael E. McConnell(Children's Healthcare of Atlanta), Nancy McCabe(Emory University), Ryan M. Ford(Emory University), Emir Veledar(University of Miami)
Cited by 208
Related Papers
Optimal Medical Therapy With or Without Percutaneous Coronary Intervention to Reduce Ischemic Burden
|Circulation|2008|1.6k
Updated International Consensus Diagnostic Criteria for Eosinophilic Esophagitis: Proceedings of the AGREE Conference
|Gastroenterology|2018|1.1k
Effect of PCI on Quality of Life in Patients with Stable Coronary Disease
|New England Journal of Medicine|2008|732
Hypoplastic Left Heart Syndrome
|Journal of the American College of Cardiology|2011|498
Sex Differences in Hospital Mortality After Coronary Artery Bypass Surgery
|Circulation|2002|399